The clinical literature on muscle has, in the last fifteen years, gone through a quiet rebranding. The thing once called "the meat that moves you around" has been rediscovered as the body's largest endocrine organ, the principal insulin sink, the primary glucose disposal route, and the buffer between a hard day and a fall. The field that studies this rebranding is sarcopenia research, and the message it has been trying to deliver to general medicine for two decades is that the loss of muscle past forty is not cosmetic. It is what determines how the seventy-year-old version of a member walks across a room.
The under-trained executive cohort knows this in the abstract and ignores it in practice. The lifting in their week is reflexive, light, and fragmented. The cardio is performed at a hard, ineffective middle pace. The protein intake is half what it should be for their lean body mass. The eight-week vacation each year reverses six months of careful work. And the slow loss of muscle that accelerates around forty — roughly one percent per year, faster after sixty — goes unmeasured because the scale weight does not change. The fat replaces the muscle silently. The number is the same. The body is a different one.
Muscle as endocrine organ
Skeletal muscle releases a class of signaling molecules called myokines into the bloodstream during and after contraction. The list of identified myokines is now in the hundreds, but a small number do most of the work that matters longitudinally. IL-6, released acutely from muscle during exercise, opposes the chronic IL-6 elevation seen in metabolic disease and produces an anti-inflammatory effect at the systemic level. Irisin, released from working muscle, modestly drives the browning of subcutaneous adipose tissue and contributes to thermogenesis. BDNF, released from muscle and brain, supports neuroplasticity and is the cleanest mechanistic story for why exercise is the single most reliable intervention for cognitive function in aging adults.
What this list adds up to is a body that is, in the language of the Bente Klarlund Pedersen group at Copenhagen, "metabolically conversational." Muscle that is regularly contracted is in dialogue with liver, adipose, brain, and immune system through a chemical signal that the sedentary muscle does not send. The signal is dose-dependent. The dose comes from training.
Muscle as insulin sink
Skeletal muscle accounts for roughly seventy to eighty percent of insulin-mediated glucose disposal in the postprandial state. The size of the muscle, the density of its mitochondria, and the responsiveness of its insulin receptors collectively determine how a meal is metabolized. A larger, better-trained muscle pool buffers a high-glycemic meal in a way that a smaller, less-trained one cannot. The same plate of pasta is two different metabolic events in two different bodies, and the difference is most often muscle.
The corollary is the one we discuss with members: insulin sensitivity is a structural property as much as a behavioral one. The lean diabetic exists. The metabolically obese normal-weight phenotype exists. Both are diagnoses of insufficient muscle mass relative to the metabolic demands of the diet, and both respond to resistance training in dose-response fashion. The Mauvais-Jarvis lab and the Defronzo group have spent two decades documenting that resistance training improves insulin sensitivity in pre-diabetic and diabetic populations independent of weight loss. The lesson is not that you have to lose weight to fix insulin. The lesson is that you have to build muscle.
Muscle as fall insurance
The single highest-resolution predictor of all-cause mortality in adults over sixty-five is a member's grip strength. Not because grip strength is causal — it is not — but because grip is a clean proxy for total-body muscle quality, and total-body muscle quality is the structural property on which independent living, balance, fall avoidance, and recovery from acute illness depend. The Norman et al. analysis, which pooled grip-strength data across a half-million adults, produced effect sizes that exceeded those of most pharmacologic interventions in the same age band.
What that means in practice is that the eighty-year-old member who can grip the chair-rail and hold their own weight does not fall on the way to the bathroom at three in the morning. The same member, fifteen years earlier, was the fifty-five-year-old who maintained a deadlift program with their coach. The chain runs through every decade between those two points.
What the dosing looks like
The minimum effective dose for muscular hypertrophy and strength preservation in adults over forty, as established by the Schoenfeld and Helms reviews and confirmed across the major training-load meta-analyses, is roughly ten to twenty hard sets per muscle group per week, distributed across two to four sessions, with each working set taken to within one to three repetitions of failure. Below ten weekly sets, the response is small. Above twenty, returns plateau and recovery cost rises. The window between is where most members should live.
The repetition range is more permissive than the bro-science of the 1990s suggested. Hypertrophy occurs across a wide range — six to thirty repetitions per set — provided the set is taken close to muscular failure. Heavy and low-rep sets favor strength and bone density. Moderate-and-mid-rep work favors hypertrophy. High-rep sets to failure produce hypertrophy with less joint cost and are particularly valuable for the over-fifty cohort whose joints are no longer interested in the lower-rep heavy work.
The protein floor is one to two grams per kilogram of lean body mass per day, distributed across three to four meals, with the post-training meal containing at least thirty to forty grams of high-quality protein within two to four hours of the session. The leucine threshold — roughly two and a half grams per meal — is the trigger for muscle protein synthesis, and animal-source proteins reach it more easily per gram than plant-source. Plant-based members can get there; the calculus is more demanding and the dose is larger.
What this looks like on our floor
For the member over forty, the program is three semi-private sessions per week, programmed against a documented baseline. Lower body, upper body, full-body conditioning, rotated weekly. Progressive overload tracked through the member dashboard, with five to ten percent jumps logged when the working set begins to feel routine. Two self-directed days per week of either Zone 2 cardio or accessory work. One session per week of mobility or recovery. The body composition is measured by DEXA at intake and quarterly thereafter. The lean mass number is the one we watch most carefully.
The member who follows this program for one year typically gains three to six pounds of lean mass while losing four to ten pounds of fat. The scale weight may not move much. The bloodwork moves. The morning glucose moves. The thirty-second-chair-stand moves. The face that looks back from the mirror at year's end is, in the language of one of our long-tenured members, "the face I had at thirty-eight, which I did not realize I had liked at the time."
That outcome is not the consequence of hypertrophy alone. It is the consequence of the medical, nutritional, and recovery framework around it. But the hypertrophy is the load-bearing wall. Remove it and the rest of the framework has nothing to support.
Hypertrophy is medicine. The next ten years will, we suspect, formalize that fact in the way the last ten years formalized Zone 2. Most of our members will not need the formalization. They are already at the bench.
— Published in The Bioneer, Journal.